Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer wins contract to make Servier’s gevokizumab

August 7, 2012
Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody

Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …

News
AZ app image

AstraZeneca launches prostate cancer app

August 7, 2012
Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

News
richard-vellacott

Horizon Discovery appoints chief financial officer

August 7, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott

Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …

Appointment

What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry

August 7, 2012
Sales and Marketing e-detailing, sales, sales reps

E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …

Feature
Thought Leadership
Pfizer image

Pfizer/Janssen Alzheimer’s drug dropped after failure

August 7, 2012
Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …

News

Opposition mounting to EU’s API import regulations

August 7, 2012
Manufacturing and Production API, EU, TBT, WTO, manufacturing

Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …

News
merck_incweb

Merck’s Singulair faces generic rivals

August 7, 2012
Sales and Marketing Merck, Singulair, generic erosion, patent

Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …

News
ABPI image

Whitehead to GPs: don’t squeeze the drugs budget

August 7, 2012
Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform

GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …

News
Rawlins image

Sue NHS to ensure access to drugs, says NICE chief

August 6, 2012
Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology

 The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …

News

Novartis and Pennsylvania team up on cancer research

August 6, 2012
Research and Development Cancer, Novartis, University of Pennsylvania, chimeric antigen receptor

Novartis and the University of Pennsylvania have joined forces to investigate a method of treating cancer which encourages patients’ immune …

News

Sanofi’s colorectal cancer drug gains FDA approval

August 6, 2012
Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer

The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …

News
ian_broadway

Talentmark appoints director of Managed Services

August 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark

Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …

Appointment
ABPI image

ABPI outlines vision for drug pricing reform

August 3, 2012
Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …

News
GSK image

GSK submits melanoma drugs for regulatory approval

August 3, 2012
Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology

GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …

News

Government healthcare fund pays up

August 3, 2012
Research and Development, Sales and Marketing ABPI, MRC, SMEs, government

A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …

News
dr

Teva makes two senior executive appointments

August 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Aharon (Arik) Yaari, Carlo De Notaristefani, Teva

Teva has announced the appointments of Dr Carlo De Notaristefani as president and chief executive of Global Operations, and Aharon …

Appointment
susan_thiele_headshot

Susan Thiele appointed US head of healthcare

August 3, 2012
Medical Communications Hill+Knowlton, susan thiele

Communications firm Hill+Knowlton Strategies has announced the appointment of Susan Thiele as US healthcare practice leader. Thiele has been with …

Appointment
Pfizer Sandwich image

Pfizer Sandwich site sold to private consortium

August 3, 2012
Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …

News
Shire image

Shire posts strong quarter results

August 2, 2012
Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

News

Bristol-Myers Squibb halts Hep C pill study

August 2, 2012
Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension

Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026